BEEBE KATHERINE (Chief Scientific Officer) received a stock award from TITAN PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/28/2023ACC: 0000921895-23-001755
Officer· Chief Scientific Officer
Since Feb 2019
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
New position
7/26/2023
0.00→50K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/26/2023 | A · Award | +50K | — | — | New position | 0.00 | 50K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
100K shares
Shares
+100K
Strike price
1.31
Held after
100K
Exercisable
—
6/29/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock100K shares | 6/29/2023 | A · Award | +100K | 1.31 | — | 100K |